Dongkoo Bio&Pharma strengthens dermatology lineup with ‘Betatriol’
After successfully avoiding the patent of the psoriasis treatment ‘Daivobet(Product name of Dongkoo Bio&Pharma: Betatriol),’ Dongkoo Bio&Pharma(CEO Yong-Jun Cho) is actively working on commercialization of its product.
The Intellectual Property Tribunal raised the hand of Dongkoo at the patent n...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
